Nature ( IF 50.5 ) Pub Date : 2024-09-04 , DOI: 10.1038/s41586-024-07923-x Mark A Katz 1 , Edith M Sawyer 1 , Luke Oriolt 1 , Albina Kozlova 1 , Madison C Williams 1 , Shally R Margolis 1 , Matthew Johnson 2 , Joseph Bondy-Denomy 2 , Alexander J Meeske 1
Prokaryotic CRISPR–Cas immunity is subverted by anti-CRISPRs (Acrs), which inhibit Cas protein activities when expressed during the phage lytic cycle or from resident prophages or plasmids1. Acrs often bind to specific cognate Cas proteins, and hence inhibition is typically limited to a single CRISPR–Cas subtype2. Furthermore, although acr genes are frequently organized together in phage-associated gene clusters3, how such inhibitors initially evolve has remained unclear. Here we investigated the Acr content and inhibition specificity of diverse Listeria isolates, which naturally harbour four CRISPR–Cas systems (types I-B, II-A, II-C and VI-A). We observed widespread antagonism of CRISPR, which we traced to 11 previously unknown and 4 known acr gene families encoded by endogenous mobile elements. Among these were two Acrs that possess sequence homology to type I-B Cas proteins, one of which assembles into a defective interference complex. Surprisingly, an additional type I-B Cas homologue did not affect type I immunity, but instead inhibited the RNA-targeting type VI CRISPR system by means of CRISPR RNA (crRNA) degradation. By probing viral sequence databases, we detected abundant orphan cas genes located within putative anti-defence gene clusters. Among them, we verified the activity of a particularly broad-spectrum cas3 homologue that inhibits type I-B, II-A and VI-A CRISPR immunity. Our observations provide direct evidence of Acr evolution by cas gene co-option, and new genes with potential for broad-spectrum control of genome editing technologies.
中文翻译:
多种病毒 cas 基因拮抗 CRISPR 免疫
原核 CRISPR-Cas 免疫被抗 CRISPR (Acrs) 破坏,当在噬菌体裂解周期中表达或从常驻原噬菌体或质粒表达时,抗 CRISPR 会抑制 Cas 蛋白活性1。Acrs 通常与特定的同源 Cas 蛋白结合,因此抑制通常仅限于单个 CRISPR-Cas 亚型2。此外,尽管 acr 基因经常在噬菌体相关基因簇中组织在一起3,但这些抑制剂最初是如何进化的尚不清楚。在这里,我们研究了不同李斯特菌分离株的 Acr 含量和抑制特异性,这些分离株天然含有四种 CRISPR-Cas 系统 (I-B、II-A、II-C 和 VI-A 型)。我们观察到 CRISPR 的广泛拮抗作用,我们将其追溯到由内源性移动元件编码的 11 个以前未知的 acr 基因家族和 4 个已知的 acr 基因家族。其中包括两种与 I-B 型 Cas 蛋白具有序列同源性的 Acr,其中一种组装成有缺陷的干扰复合物。令人惊讶的是,额外的 I-B 型 Cas 同源物并不影响 I 型免疫,而是通过 CRISPR RNA (crRNA) 降解抑制了靶向 RNA 的 VI 型 CRISPR 系统。通过探测病毒序列数据库,我们检测到了位于推定的抗防御基因簇内的大量孤儿 cas 基因。其中,我们验证了一种特别广谱的 cas3 同系物的活性,该同源物抑制 I-B 、 II-A 和 VI-A CRISPR 免疫。我们的观察结果提供了通过 cas 基因共选择进化 Acr 的直接证据,以及具有广谱控制基因组编辑技术潜力的新基因。